Espinoza Octavio

Insider profile

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return 5% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
12 0% Buy
34 71% Buy
47 69% Buy
Espinoza Octavio's trades of Ligand Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-03-13 2026-03-11 PlS Planned sale
92,599 +13.4%
126.84
US$4,851,650
92,599 +13.4% 126.84 US$4,851,650
2026-03-11 2026-03-11 PrS Proposed sale
56,019
214.42
US$2,081,979
56,019 214.42 US$2,081,979
2026-03-06 2026-03-04 PlS Planned sale
40,558 +10.6%
370.10
US$342,727
40,558 +10.6% 370.10 US$342,727
2026-03-06 2026-03-04 PlS Planned sale
2,457 -8.9%
207.91
US$510,823
2,457 -8.9% 207.91 US$510,823
2026-03-06 2026-03-04 PlS Planned sale
1,588 -5.5%
206.89
US$328,542
1,588 -5.5% 206.89 US$328,542
2026-03-06 2026-03-04 PlS Planned sale
1,457 -4.8%
205.79
US$299,841
1,457 -4.8% 205.79 US$299,841
2026-03-06 2026-03-04 PlS Planned sale
743 -2.4%
204.74
US$152,125
743 -2.4% 204.74 US$152,125
2026-03-06 2026-03-04 PlS Planned sale
668 -2.1%
203.63
US$136,024
668 -2.1% 203.63 US$136,024
2026-03-06 2026-03-04 PlS Planned sale
697 -2.1%
202.79
US$141,343
697 -2.1% 202.79 US$141,343
2026-03-06 2026-03-04 PlS Planned sale
950 -2.8%
201.73
US$191,640
950 -2.8% 201.73 US$191,640
2026-03-06 2026-03-04 PlS Planned sale
698 -2.0%
201.09
US$140,364
698 -2.0% 201.09 US$140,364
2026-03-06 2026-03-04 PlS Planned sale
53 -0.2%
200.08
US$10,604
53 -0.2% 200.08 US$10,604
2026-03-06 2026-03-04 PlS Planned sale
699 -2.0%
198.71
US$138,895
699 -2.0% 198.71 US$138,895
2026-03-04 2026-03-04 PrS Proposed sale
13,423
204.24
US$2,741,514
13,423 204.24 US$2,741,514
2025-12-16 2025-12-12 S Sale
1,804 -6.4%
188.31
US$339,711
1,804 -6.4% 188.31 US$339,711
2025-12-12 2025-12-12 PrS Proposed sale
1,804
188.31
US$339,711
1,804 188.31 US$339,711
2025-05-13 2025-05-09 PP Planned purchase
500 +1.8%
104.40
US$52,200
500 +1.8% 104.40 US$52,200
2025-05-13 2025-05-09 PP Planned purchase
1,000 +3.8%
103.89
US$103,890
1,000 +3.8% 103.89 US$103,890
2025-03-06 2025-03-04 S Sale
5,000 -20.9%
115.03
US$575,148
5,000 -20.9% 115.03 US$575,148
2025-03-04 2025-03-04 PrS Proposed sale
5,000
115.03
US$575,149
5,000 115.03 US$575,149
2024-12-26 2024-12-23 S Sale
2,104 -9.2%
116.37
US$244,850
2,104 -9.2% 116.37 US$244,850
2024-12-23 2024-12-23 PrS Proposed sale
2,104
116.37
US$244,851
2,104 116.37 US$244,851
2024-09-24 2024-09-20 S Sale
800 -3.1%
103.95
US$83,160
800 -3.1% 103.95 US$83,160
2024-09-24 2024-09-20 S Sale
275 -1.1%
103.86
US$28,562
275 -1.1% 103.86 US$28,562
2024-09-24 2024-09-20 S Sale
200 -0.8%
103.98
US$20,796
200 -0.8% 103.98 US$20,796
2024-09-20 2024-09-20 PrS Proposed sale
1,275
103.94
US$132,518
1,275 103.94 US$132,518
2024-05-17 2024-05-17 PrS Proposed sale
5,156
86.66
US$446,844
5,156 86.66 US$446,844
2024-05-17 2024-05-17 S Sale
134 -0.6%
86.65
US$11,611
134 -0.6% 86.65 US$11,611
2024-05-17 2024-05-17 S Sale
5,022 -17.6%
86.67
US$435,233
5,022 -17.6% 86.67 US$435,233
2024-05-17 2024-05-16 S Sale
2,264 -9.5%
86.00
US$194,712
2,264 -9.5% 86.00 US$194,712
2024-05-16 2024-05-16 PrS Proposed sale
2,264
86.00
US$194,712
2,264 86.00 US$194,712
2024-05-17 2024-05-15 S Sale
5,873 -19.7%
86.01
US$505,148
5,873 -19.7% 86.01 US$505,148
2024-05-15 2024-05-15 PrS Proposed sale
5,873
86.01
US$505,149
5,873 86.01 US$505,149
2024-02-29 2024-02-28 PrS Proposed sale
140
88.46
US$12,384
140 88.46 US$12,384
2024-02-29 2024-02-28 S Sale
140 -0.5%
88.46
US$12,384
140 -0.5% 88.46 US$12,384
2024-02-28 2024-02-28 PrS Proposed sale
27,725
88.72
US$2,459,800
27,725 88.72 US$2,459,800
2022-11-10 2022-11-09 S Sale
1,696 -16.1%
75.64
US$128,283
1,696 -16.1% 75.64 US$128,283